DUBLIN, Nov 16, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Professional Diagnostics Market 2016-2020" report to their offering.
The report forecasts the global professional diagnostics market to grow at a CAGR of 6.76% during the period 2016-2020.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One of latest trends in the market is launch of novel tests in lung and colon cancer influencing the market growth of PD devices. Targeted genetic testing for cancer that is available to molecular pathologists is a unique combination of ease of use, cost-effectiveness, reliability, and sensitivity. Multiplexed assays reduce the cost and turnaround time compared with existing methods by allowing the user to simultaneously analyze the relevant oncogenes. The two test panels help in personalizing treatment and improving patient care with rapid analysis of clinically actionable mutations occurred in lung and colon cancer.
According to the report, one of the primary drivers in the market is increasing industrial partnerships driving the growth of the market. Companies of different financial caliber compete in the medical devices, which includes professional diagnostics devices. Some are more specialized with respect to particular markets, and others have higher financial resources. New companies have entered the areas of blood coagulation, safety-engineered devices, and life sciences. Established companies have broadened their business activities into medical technology. These initiatives aim to leverage each other's unique selling propositions (USPs), such as strong customer bases, technology and strong financial and R&D capabilities. This has resulted in many partnerships between companies to increase their market share.
Further, the report states that one major challenge in the market is professional challenges in clinical microbiology and infectious diseases in Europe.
- Abbott Diagnostics
- Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by end-user
Part 08: Geographical segmentation
Part 09: Market drivers
Part 10: Impact of drivers
Part 11: Market challenges
Part 12: Impact of drivers and challenges
Part 13: Market trends
Part 14: Vendor landscape
Part 15: Key vendor analysis
Part 16: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/kn76pj/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets